COMPANY
BiaCure Therapies
Funding and NIH signals
- NIH award NIH awarded $1M (SBIR Phase II 5R44AI188772-02, continuation, notice May 22, 2026). NIH RePORTER 5R44AI188772-02 (May 22, 2026)
Evidence (1 event)
- May 22, 2026 · NIH RePORTER 5R44AI188772-02
Organization: BIACURE THERAPIES, INC.; City/State: Waukesha, WI; Project number: 5R44AI188772-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-22; FY total cost (award amount): 1000000; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Using Targeted, Controlled High Frequency Energy for Treatment of Onychomycosis; Organization type: Domestic For-Profits
- May 22, 2026 · NIH RePORTER 5R44AI188772-02